AN ACT TO AMEND TITLE 29 OF THE DELAWARE CODE RELATING TO THE DELAWARE DIABETES WELLNESS PILOT PROGRAM WITHIN THE DEPARTMENT OF HUMAN RESOURCES TO STUDY PREDIABETIC AND DIABETIC WELL CARE.
HB163 establishes the Delaware Diabetes Wellness Pilot Program within the Department of Human Resources to study whether a more proactive, technology-assisted approach to diabetes care can improve outcomes and reduce costs for state employees and dependents enrolled in the Delaware Group Health Insurance Plan. The bill directs the Secretary of Human Resources to partner with a Delaware health system, physicians, and a technology company to recruit 400 to 500 volunteer participants with diabetes, collect baseline and follow-up health data, and use real-time monitoring and individualized care plans to track changes over time.
The pilot is designed as an observational study centered on “measure and manage” care, including continuous glucose monitoring or similar tools, regular laboratory testing, dietary counseling, lifestyle medicine support, and tracking of utilization measures such as primary care visits, emergency visits, and hospitalizations. The bill also contemplates use of the Delaware Grown initiative to connect participants with fresh, locally grown foods and requires reporting through the Delaware Health Information Network (DHIN) every six months, with a final analytic report at the end of the study.
The bill amends Title 29 of the Delaware Code to create a new subchapter establishing the pilot program, setting out the Department of Human Resources’ authority to administer it, and requiring coordination with DHIN, the Statewide Benefits and Insurance Coverage division, and participating providers. It also requires HIPAA-compliant data handling, a control group for comparison, periodic reporting to state officials, and a sunset after three years unless extended by the General Assembly. If the pilot shows positive results, the Secretary may discontinue the study and seek expansion to additional Delawareans or other health plans.
The bill appears to have broad bipartisan sponsorship and is framed in strongly supportive terms, with the synopsis emphasizing improved health outcomes and lower long-term costs. The legislative findings and structure suggest a positive, reform-oriented sentiment focused on innovation, prevention, and cost containment in diabetes care. No committee transcript or vote record was provided, so there is no recorded floor or committee opposition in the supplied materials.
The main policy tension is between supporters’ emphasis on proactive lifestyle- and technology-based diabetes management and potential concerns about the bill’s reliance on a pilot study, vendor selection, and data collection from health plan participants. The bill’s findings make strong claims about diabetes costs, medication side effects, and the benefits of dietary intervention, which could invite debate over medical assumptions, program effectiveness, and whether the state should prioritize this model over other public health strategies. Any concern about privacy, provider burden, or the use of state health data would likely center on the DHIN reporting structure and the requirement that participants and their physicians engage in the program voluntarily.